The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.41BCNY
211.09M · vs all stocks (USD)
Updated Oct 22, 2026
Revenue (TTM)
1.20BCNY
180.01M · vs all stocks (USD)
Updated Oct 22, 2026
Profit Margin
-0.80%
vs Conglomerates peers
Updated Oct 22, 2026
Beta
-0.5710x
vs all stocks
Updated Oct 22, 2026
52-Week Change
-69.19%
vs all stocks
Updated Oct 22, 2026
Market Capitalization
1.41BCNY
211.09M · vs all stocks (USD)
Updated Oct 22, 2026
Enterprise Value
1.80BCNY
269.29M · vs all stocks (USD)
Updated Oct 22, 2026
Price to Sales (TTM)
1.17x
vs Conglomerates peers
Updated Oct 22, 2026
Price to Book (MRQ)
2.68x
vs Conglomerates peers
Updated Oct 22, 2026
Enterprise to Revenue
1.50x
vs Conglomerates peers
Updated Oct 22, 2026
Enterprise to EBITDA
12.46x
vs Conglomerates peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 14.29×.Updated Oct 22, 2026
Gross Margin
15.35%
vs Conglomerates peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 18.41%.Updated Oct 22, 2026
Profit Margin
-0.80%
vs Conglomerates peers
Updated Oct 22, 2026
Operating Margin
9.59%
vs Conglomerates peers
Updated Oct 22, 2026
Return on Assets (TTM)
3.41%
vs Conglomerates peers
Updated Oct 22, 2026
Return on Equity (TTM)
4.89%
vs Conglomerates peers
Updated Oct 22, 2026
Revenue (TTM)
1.20BCNY
180.01M · vs all stocks (USD)
Updated Oct 22, 2026
Revenue per Share (TTM)
1.39CNYUpdated Oct 22, 2026
Quarterly Revenue Growth
13.20%
vs Conglomerates peers
Updated Oct 22, 2026
Gross Profit (TTM)
221.05MCNY
33.13M · vs all stocks (USD)
Updated Oct 22, 2026
EBITDA (TTM)
125.69MCNY
18.84M · vs all stocks (USD)
Updated Oct 22, 2026
Net Income (TTM)
-9.58MCNY
-1.44M · vs all stocks (USD)
Updated Oct 22, 2026
Quarterly Earnings Growth (YoY)
-28.80%
vs Conglomerates peers
Updated Oct 22, 2026
Operating Cash Flow (TTM)
-1.51MCNY
-226.12K · vs all stocks (USD)
Updated Oct 22, 2026
Levered Free Cash Flow (TTM)
-37.00MCNY
-5.55M · vs all stocks (USD)
Updated Oct 22, 2026
Payout Ratio
0.00%
vs Conglomerates peers
Updated Oct 22, 2026
Minority Interest (Equity)
726.74MCNYFY2025 · Dec 31, 2025
Revenue
1.15BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
896.34MCNYFY2025 · Dec 31, 2025
Gross Profit
249.18MCNYFY2025 · Dec 31, 2025
Operating Income
127.50MCNY
19.11M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
132.16MCNYFY2025 · Dec 31, 2025
Income Tax Expense
40.74MCNYFY2025 · Dec 31, 2025
Net Income
91.42MCNYFY2025 · Dec 31, 2025
EBIT
133.76MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
170.48MCNYFY2025 · Dec 31, 2025
Research & Development
8.10MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
34.70MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
9.48MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
4.30MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
1.59MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.0040CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.0040CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
867.71MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
867.71MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
91.42MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-87.95MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-301.10MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-397.97MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
308.88MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
91.42MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
-135.07KCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-354.38MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-38.01MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-96.87MCNYFY2025 · Dec 31, 2025
Net Acquisitions
-8.85MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-105.71MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
20.00MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-11.30MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-602.14KCNYFY2025 · Dec 31, 2025
Other Financing Charges
-40.96MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-32.87MCNYFY2025 · Dec 31, 2025
Shares Outstanding
863.98MSharesUpdated Oct 22, 2026
Float Shares
617.80MSharesUpdated Oct 22, 2026
% Held by Insiders
29.83%
vs all stocks
Updated Oct 22, 2026
% Held by Institutions
0.00%
vs all stocks
Updated Oct 22, 2026
Total Cash (MRQ)
398.42MCNY
59.72M · vs all stocks (USD)
Updated Oct 22, 2026
Total Cash per Share (MRQ)
0.4610CNYUpdated Oct 22, 2026
Total Debt (MRQ)
47.38MCNY
7.10M · vs all stocks (USD)
Updated Oct 22, 2026
Total Debt to Equity (MRQ)
0.0374x
vs Conglomerates peers
Updated Oct 22, 2026
Current Ratio (MRQ)
2.26x
vs Conglomerates peers
Updated Oct 22, 2026
Book Value per Share (MRQ)
0.6090CNYUpdated Oct 22, 2026
Total Assets
699.17MCNY
104.80M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Liabilities
905.51MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
699.17MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
48.48MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
857.03MCNYFY2025 · Dec 31, 2025
Cash
311.11MCNYFY2025 · Dec 31, 2025
Cash Equivalents
168.82MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
479.93MCNYFY2025 · Dec 31, 2025
Accounts Receivable
264.39MCNYFY2025 · Dec 31, 2025
Inventory
395.48MCNYFY2025 · Dec 31, 2025
Accounts Payable
253.01MCNYFY2025 · Dec 31, 2025
Short-term Debt
34.35MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
106.13MCNYFY2025 · Dec 31, 2025
Long-term Debt
9.56MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
863.98MCNYFY2025 · Dec 31, 2025
Retained Earnings
-1.27BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.24BCNY
185.16M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
1.38CNYUpdated Oct 22, 2026
52-Week High
5.51CNYUpdated Oct 22, 2026
52-Week Change
-69.19%
vs all stocks
Updated Oct 22, 2026
Beta
-0.5710x
vs all stocks
Updated Oct 22, 2026
50-Day MA
1.75CNYUpdated Oct 22, 2026
200-Day MA
2.87CNYUpdated Oct 22, 2026
Avg 10-Day Volume
18.45MSharesUpdated Oct 22, 2026
Avg 30-Day Volume
24.97MSharesUpdated Oct 22, 2026
Diluted EPS (TTM)
-0.0100CNYUpdated Oct 22, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
It gets more sales from its assets than its industry does, and a lot of profit from them too.
Reads
Industry-Benchmarked Return on Capital Elevated
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Supply Chain
Upstream position: supplies 8 industries, depends on 0Notable
Outgoing: 8.00Incoming: 0.00
Companies that share the same coordination system — how they create, deliver, or capture value.